share_log

Insiders Of Enovix Retain US$712k Of Investment Selling At Higher Prices

Insiders Of Enovix Retain US$712k Of Investment Selling At Higher Prices

Enovix內部人士以更高的價格出售其總計價值爲712,000美元的持股
Simply Wall St ·  06/26 21:01

Despite a 30% gain in Enovix Corporation's (NASDAQ:ENVX) stock price this week, shareholders shouldn't let up. The fact that insiders chose to dispose of US$712k worth of stock in the past 12 months even though prices were relatively low could be indicative of some anticipated weakness.

儘管Enovix Corporation (納斯達克: ENVX) 的股價上漲了30%,但股東們不應該懈怠。過去12個月中,內部人士即使價格相對較低,仍選擇出售價值712,000美元的股票,這可能意味着一些預期弱點。

Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.

雖然我們不認爲股東應該簡單地跟隨內部交易,但我們認爲監控內部人士的行動是很合理的。

The Last 12 Months Of Insider Transactions At Enovix

在Enovix的上一年度的內部交易中,獨立董事Betsy Atkins進行了最大的內部交易。那筆交易是以16.25美元的價格每股585,000美元的股票進行的。那意味着即使股價略低於目前的16.26美元,內部人士還是想套現一些股票。通常情況下,當內部人士以低於當前價格的價格出售時,我們認爲這是令人沮喪的,因爲這意味着他們滿意較低的估值。但是,雖然內部賣出有時是令人沮喪的,但這只是一個弱信號。這個銷售僅佔Betsy Atkins股份總額的19%。

The Independent Director, Betsy Atkins, made the biggest insider sale in the last 12 months. That single transaction was for US$585k worth of shares at a price of US$16.25 each. That means that even when the share price was slightly below the current price of US$16.26, an insider wanted to cash in some shares. As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. However, while insider selling is sometimes discouraging, it's only a weak signal. This single sale was just 19% of Betsy Atkins's stake.

總體來說,內部人士在過去一年中賣出了比買進更多的Enovix股票。下面的圖表顯示了過去一年(由公司和個人)的內部交易。如果您想知道誰以多少價錢何時賣出了股票,請單擊下面的圖表!

All up, insiders sold more shares in Enovix than they bought, over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

總的來說,在過去的一年中,Enovix內部人士賣出的股票比買入的要多。下面的圖表顯示了過去一年內內部人士(包括公司和個人)的交易情況。如果您想要知道準確的賣出者、價格和時間,請直接點擊下面的圖表!

insider-trading-volume
NasdaqGS:ENVX Insider Trading Volume June 26th 2024
納斯達克:ENVX股票的內部交易量2024年6月26日

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

對於那些喜歡發現潛力股票的人,可以免費查看最新內部交易股票的小盤公司名單,這可能正是您要找的機會。

Insiders At Enovix Have Sold Stock Recently

Enovix的內部人士最近出售了股票

The last quarter saw substantial insider selling of Enovix shares. In total, insiders sold US$127k worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.

上個季度,Enovix的內部人士大量出售了股票。總體而言,內部人士在那段時間內出售了價值127,000美元的股票,而我們則沒有記錄任何購買。考慮到這一點,很難爭論所有內部人士都認爲這些股票是便宜貨。

Insider Ownership

內部人員持股情況

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It's great to see that Enovix insiders own 16% of the company, worth about US$429m. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

許多投資者喜歡查看內部人員擁有多少公司股份。高內部人員持股往往使公司領導更加關注股東利益。很高興看到Enovix的內部人員擁有公司的16%股份,價值約4.29億美元。這種內部人員的重要所有權通常會增加公司以所有股東的利益運行的機會。

So What Do The Enovix Insider Transactions Indicate?

那麼Enovix的內部交易意味着什麼?

Insiders sold Enovix shares recently, but they didn't buy any. Despite some insider buying, the longer term picture doesn't make us feel much more positive. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. Be aware that Enovix is showing 3 warning signs in our investment analysis, and 1 of those is significant...

內部人員最近出售了Enovix的股票,但他們沒有購買任何股票。儘管有一些內部購買,但長期情況並沒有令我們感到更加積極。該公司擁有較高的內部人員持股,但鑑於股票銷售的歷史,我們還是有些猶豫。因此,雖然了解內部人員的買賣情況很有幫助,但了解特定公司面臨的風險也很有幫助。請注意,Enovix在我們的投資分析中顯示出3個警告信號,其中一個是重要的...

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

如果你想查看其他公司——那些具有開多淨資產收益率和低負債的有趣公司的免費清單——那麼不要錯過這個機會。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者發送電子郵件至editorial-team@simplywallst.com。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論